Recognizing exceptional leadership in patient education and clinical skill in the GammaTile procedure
GT Medical Technologies, a medical device company focused on improving the Saint Louis lives of patients with brain tumors, announced SSM Health Saint Louis University Hospital as the latest GammaTile Center of Excellence Program designation.
The program recognizes leaders in patient care dedicated to advancing brain tumor treatment. Physicians and their institutions who receive this designation have demonstrated an exceptional level of expertise in the GammaTile procedure by meeting specific clinical criteria, annual case minimums, and ongoing education requirements.
Health Technology Insights: John Snow Labs Acquires WiseCube to Enhance Medical AI Safety
The following physicians are now recognized with achievement:
- Philippe Mercier, MD, PhD, Associate Professor, Division Director, Neurosurgery
- Jeroen Coppens, MD, Professor, Neurosurgery
- Joanna Kemp, MD, Associate Professor, Neurosurgery
- Maheen Khan, MD, Assistant Professor, Neurosurgery
- John Dombrowski, MD, PhD, Associate Professor, Radiation Oncology
- Christen R. Elledge, MD, Assistant Professor, Radiation Oncology
Health Technology Insights: Abbott’s Tendyne Gets FDA Nod for Minimally Invasive Valve Replacement
“At SSM Health Saint Louis University we have developed a comprehensive neuro-oncology program with subspecialty trained neurosurgeons who incorporate the latest technology to improve the lives of our cancer patients,” said Dr. Philippe Mercier, MD, PhD, associate professor and director of neuroscience at Saint Louis University, SLUCare and SSM Health Saint Louis University Hospital neurosurgeon. “GammaTile allows us to offer another option in the treatment of malignant brain tumors. We are also participating in multiple clinical trials which will help us further define the optimal use of GammaTile.”
GammaTile is an innovative form of radiation therapy placed at the time of tumor removal surgery, delivering immediate, targeted radiation to the tumor site when cancer cells are most vulnerable. Unlike conventional approaches, which at their lowest often require a delay between surgery and radiation therapy to allow for wound healing, GammaTile eliminates this treatment gap. By delivering immediate, localized radiation directly at the tumor site, it is designed to maximize the treatment’s effectiveness against remaining cancer cells and reduce the risk of regrowth.
Health Technology Insights: Forte Medical Transforms Women’s Health with Peezy Midstream
To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com
Source – PR Newswire
